Epigenomic and Transcriptomic Changes in the Onset of Disease
dc.contributor.author | Naler, Lynette Brigitte | en |
dc.contributor.committeechair | Lu, Chang | en |
dc.contributor.committeemember | Tong, Rong | en |
dc.contributor.committeemember | Goldstein, Aaron S. | en |
dc.contributor.committeemember | Davis, Richey M. | en |
dc.contributor.department | Chemical Engineering | en |
dc.date.accessioned | 2021-05-20T08:00:40Z | en |
dc.date.available | 2021-05-20T08:00:40Z | en |
dc.date.issued | 2021-05-19 | en |
dc.description.abstract | Current sequencing technologies allows researchers unprecedented insight into our biology, and how these biological mechanisms can become distorted and lead to disease. These aberrant mechanisms can be brought about by many causes, but some occur as a result of genetic mutations or external factors through the epigenome. Here, we used our microfluidic technology to profile the epigenome and transcriptome to study such aberrant mechanisms in three different diseases and illnesses: breast cancer, chronic inflammation, and mental illness. We profiled the epigenome of breast tissue from healthy women with the BRCA1 mutation to understand how the mutation may facilitate eventual breast cancer. Epigenomic changes in breast cells suggest that cells in the basal compartment may differentiate into a different cell type, and perhaps become the source of breast cancer. Next, we compared the epigenome and genome of murine immune cells under low-grade inflammation and acute inflammation conditions. We found that low-grade inflammation preferentially utilizes different signaling pathways than in acute inflammation, and this may lead to a non-resolving state. Finally, we analyzed the effect of the maternal immune activation on unborn offspring, and how these changes could cause later mental illness. The insights we made into these diseases may lead to future therapies. | en |
dc.description.abstractgeneral | Despite advances in medical and scientific research, there is still a dearth of information on how diseases affect the expression of our genes, such as breast cancer, chronic inflammation, and influenza. Mutation in the BRCA1 gene is probably the most well-known mutation that can lead to breast cancer. We know the overarching reason that mutation in BRCA1 can lead to cancer, as BRCA1 is responsible for repairing damage in the DNA, so mutations can compound and create cancerous cells. However, we do not know the exact mechanisms by which this actually happens. Another widespread problem is chronic inflammation, which can promote or lead to diseases such as diabetes, cancer, Alzheimer's, Rheumatoid arthritis, and heart disease. In addition, there are many causes of chronic inflammation that many people have experienced at some point in time, including stress, insomnia, being sedentary, poor eating habits, and obesity. Despite this, we still do not fully understand why chronic inflammation differs from normal inflammation, which is a healthy process, or why it does not resolve. There are also other connections that are surprising, and many are not aware of. If a pregnant woman gets the flu during her second trimester, her baby has much higher odds of developing schizophrenia later in its lifetime. Given the prevalence of the flu, there is a very real chance that an expecting mother will be infected during her pregnancy. | en |
dc.description.degree | Doctor of Philosophy | en |
dc.format.medium | ETD | en |
dc.identifier.other | vt_gsexam:30377 | en |
dc.identifier.uri | http://hdl.handle.net/10919/103388 | en |
dc.publisher | Virginia Tech | en |
dc.rights | In Copyright | en |
dc.rights.uri | http://rightsstatements.org/vocab/InC/1.0/ | en |
dc.subject | Epigenomics | en |
dc.subject | Transcriptomics | en |
dc.subject | Chromatin Immunoprecipitation | en |
dc.subject | RNA Sequencing | en |
dc.subject | Breast Cancer | en |
dc.subject | BRCA1 | en |
dc.subject | Inflammation | en |
dc.subject | Lipopolysaccharide | en |
dc.subject | Maternal Immune Activation | en |
dc.subject | Cross-Fostering | en |
dc.title | Epigenomic and Transcriptomic Changes in the Onset of Disease | en |
dc.type | Dissertation | en |
thesis.degree.discipline | Chemical Engineering | en |
thesis.degree.grantor | Virginia Polytechnic Institute and State University | en |
thesis.degree.level | doctoral | en |
thesis.degree.name | Doctor of Philosophy | en |
Files
Original bundle
1 - 1 of 1